Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tretazicar SCHEMBL366755 | 1.00 | MAPT (1.00) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL13685668 | 0.88 | MAPT (0.78) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL5581335 | 0.88 | MAPT (0.78) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL5827945 | 0.88 | MAPT (0.78) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL3492841 | 0.86 | MAPT (0.75) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL11120951 | 0.85 | MAPT (0.74) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL3362694 | 0.84 | MAPT (0.72) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL446497 | 0.84 | MAPT (0.72) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL29391567 | 0.84 | MAPT (0.72) | MAPTCYP3A4BLMPMP22ALDH1A1 | |
| SCHEMBL3678573 | 0.84 | MAPT (0.72) | MAPTCYP3A4BLMPMP22ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602052-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | California Institute of Technology (US) | 2025-08-20 | — | — | EP | claimed |
| US-12297241-B2 | Method to engineer transplantable human tissues | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-13 | — | — | US | claimed |
| WO-2025097124-A1 | MOLECULAR SWITCH FOR INDUCIBLE GENE EXPRESSION | THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025084267-A1 | TRANSFORMANT AND METHOD FOR PRODUCING TARGET PROTEIN | 学校法人東京理科大学 | 2025-04-24 | — | — | WO | claimed |
| EP-4466354-A2 | TRANS-SPLICING RNA (TSRNA) | National University of Singapore (SG) | 2024-11-27 | — | — | EP | claimed |
| CN-118786214-A | Trans-splicing RNA (tsRNA) | 新加坡国立大学 | 2024-10-15 | — | — | CN | claimed |
| US-20240285804-A1 | ADENO-ASSOCIATED VIRAL (AAV) VECTORS FOR TISSUE-TARGETED EXPRESSION OF THERAPEUTIC GENES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-08-29 | — | — | US | claimed |
| EP-4419692-A2 | SYNTHETIC INTRONS FOR TARGETED GENE EXPRESSION | Fred Hutchinson Cancer Center (US) | 2024-08-28 | — | — | EP | claimed |
| CN-118272378-A | Method for maintaining stem property of pluripotent stem cells and removing residues thereof in differentiated cells | 呈诺再生医学科技(北京)有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4388114-A1 | CELL-TO-CELL DELIVERY OF RNA CIRCUITS | California Institute of Technology (US) | 2024-06-26 | — | — | EP | claimed |
| WO-2022212005-A9 | ACOUSTIC REMOTE CONTROL OF MICROBIAL IMMUNOTHERAPY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-11-17 | — | — | WO | claimed |
| US-20220333079-A1 | GENETICALLY MODIFIED NK CELL LINE TRANSDUCED WITH GENE ENCODING NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | SLBiGen, Inc. (KR) | 2022-10-20 | — | — | US | claimed |
| WO-2022212005-A2 | ACOUSTIC REMOTE CONTROL OF MICROBIAL IMMUNOTHERAPY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-10-06 | — | — | WO | claimed |
| CN-115151635-A | Gene-modified NK cell lines transduced with genes encoding novel chimeric antigen receptors and uses thereof | 斯比根公司 | 2022-10-04 | — | — | CN | claimed |
| CN-115054608-A | Application of cryptotanshinone substances and combination composition thereof | 澳门大学 | 2022-09-16 | — | — | CN | claimed |
| US-20220235104-A1 | NOVEL METHOD TO ENGINEER TRANSLANTABLE HUMAN TISSUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-28 | — | — | US | claimed |
| EP-4032972-A1 | GENETICALLY MODIFIED NK CELL LINE TRANSDUCED WITH GENE ENCODING NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | Slbigen Inc. (KR) | 2022-07-27 | — | — | EP | claimed |
| WO-2022125590-A1 | A SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-06-16 | — | — | WO | claimed |
| WO-2022087427-A1 | SYNTHETIC INTRONS FOR TARGETED GENE EXPRESSION | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-04-28 | — | — | WO | claimed |
| WO-2022076756-A1 | RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. (US) | 2022-04-14 | — | — | WO | claimed |